Other symptoms appear nonspecific and are related to generalized inflammation ... The most specific finding is tender or thickened temporal arteries with decreased pulsations.

What Is Takayasu's Arteritis? Arteritis is a general term that refers to the inflammation of arteries — blood vessels that carry blood away from the heart and to the rest of the body.

The FDA has approved upadacitinib, a Janus kinase inhibitor, for the treatment of giant cell arteritis in adults-marking the ...

AbbVie has received approval from the U.S. Food and Drug Administration (FDA) for RINVOQ (upadacitinib), 15 mg, once daily, ...

[1] 18 F-Flourodeoxyglucose (FDG)-PET studies show inflammation of subclavian arteries in PMR patients with negative histology of temporal arteries. Polymyalgia rheumatica and GCA are typical ...

AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA).1 ...

Musculoskeletal Doppler ultrasonography can be used to estimate levels of inflammation ... have been published on the use of temporal-artery ultrasonography for the diagnosis of giant cell ...